ALKS
Alkermes plc
Latest News for ALKS
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Wuxi Biologics (Cayman) (WXIBF) and Alkermes (ALKS) ......
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Alkermes (ALKS), ProQR (PRQR) and Simulations Plus......
In a report released today, Paul Matteis from Stifel Nicolaus maintained a Buy rating on Alkermes, with a price target of $42.00. Matteis covers th......
Analysts fell to the sidelines weighing in on Alkermes (ALKS), Apellis Pharmaceuticals (APLS) and Kalaris Therapeutics (KLRS) with neutral ratings,......
In a report released today, David Amsellem from Piper Sandler reiterated a Buy rating on Alkermes, with a price target of $43.00. Amsellem covers t......
News data is sourced from MarketXLS API and updated regularly.
Showing 5 of 5 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ALKS | $34.92 | 0% | 2.05M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |